Paper23250412
Delivery of chemotherapeutic drugs in tumour cell-derived microparticles.
Tang K and 13 others. Nat Commun, 2012. Cited by 370 papers, by iCite. Under an expression of concern.
Cite this record
ConductScience Library. Delivery of chemotherapeutic drugs in tumour cell-derived microparticles. Papers, record 23250412. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23250412
- Disease
- lung cancer261 drugs
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Connected records2
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Cell-Derived Microparticles | Major topic |
| Drug Carriers | Major topic |
| Neoplasms | Major topic |
| Animals | |
| Cell Line, Tumor | |
| Cell Membrane | |
| Cisplatin | |
| Female | |
| Liver Neoplasms | |
| Methotrexate | |
| Mice | |
| Mice, Inbred BALB C | |
| Mice, SCID | |
| Neoplasms, Experimental | |
| Ovarian Neoplasms |
Source PubMed
Trials2
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT01854866 | Safety and Effectiveness Study of Tumor Cell-derived Microparticles to Treat Malignant Ascites and Pleural Effusion | Background | ClinicalTrials.gov | |
| NCT07559097 | Exploration of the Application of Methotrexate-loaded Drug Vesicles in Intrathecal Injection for Meningeal Metastasis of Lung Cancer | Results | ClinicalTrials.gov |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Expression of concern in | 40817264 | Editorial Expression of Concern: Delivery of chemotherapeutic drugs in tumour cell-derived microparticles. | https://conductscience.org/library/papers/40817264 |
Source PubMed
References57
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20110505 | Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. | Science | 2010 | https://conductscience.org/library/papers/20110505 | PubMed |
| 2 | 18045529 | Entosis: it's a cell-eat-cell world. | Cell | 2007 | https://conductscience.org/library/papers/18045529 | PubMed |
| 3 | 21169410 | The metastasis-associated microRNA miR-516a-3p is a novel therapeutic target for inhibiting peritoneal dissemination of human scirrhous gastric cancer. | Cancer Res | 2011 | https://conductscience.org/library/papers/21169410 | PubMed |
| 4 | 19498381 | Membrane vesicles as conveyors of immune responses. | Nat Rev Immunol | 2009 | https://conductscience.org/library/papers/19498381 | PubMed |
| 5 | 21049386 | Tissue factor, lipid rafts, and microparticles. | Semin Thromb Hemost | 2010 | https://conductscience.org/library/papers/21049386 | PubMed |
| 6 | 9044858 | Neovasculature induced by vascular endothelial growth factor is fenestrated. | Cancer Res | 1997 | https://conductscience.org/library/papers/9044858 | PubMed |
| 7 | 10463618 | Augmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factor. | Cancer Res | 1999 | https://conductscience.org/library/papers/10463618 | PubMed |
| 8 | 21844207 | Actomyosin II contractility expels von Willebrand factor from Weibel-Palade bodies during exocytosis. | J Cell Biol | 2011 | https://conductscience.org/library/papers/21844207 | PubMed |
| 9 | 20873786 | Nanoparticulate alternatives for drug delivery. | ACS Nano | 2010 | https://conductscience.org/library/papers/20873786 | PubMed |
| 10 | 20861879 | Revitalizing membrane rafts: new tools and insights. | Nat Rev Mol Cell Biol | 2010 | https://conductscience.org/library/papers/20861879 | PubMed |
| 11 | 21527528 | Tumor-associated macrophages as major source of APRIL in gastric MALT lymphoma. | Blood | 2011 | https://conductscience.org/library/papers/21527528 | PubMed |
| 12 | 21808006 | Role for the actomyosin complex in regulated exocytosis revealed by intravital microscopy. | Proc Natl Acad Sci U S A | 2011 | https://conductscience.org/library/papers/21808006 | PubMed |
| 13 | 17081918 | Mechanisms of transcoelomic metastasis in ovarian cancer. | Lancet Oncol | 2006 | https://conductscience.org/library/papers/17081918 | PubMed |
| 14 | 9151784 | Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles. | J Clin Invest | 1997 | https://conductscience.org/library/papers/9151784 | PubMed |
| 15 | 20433914 | Potential neurotoxicity of nanoparticles. | Int J Pharm | 2010 | https://conductscience.org/library/papers/20433914 | PubMed |
| 16 | 15653836 | Membrane microparticles: two sides of the coin. | Physiology (Bethesda) | 2005 | https://conductscience.org/library/papers/15653836 | PubMed |
| 17 | 20830711 | Increased efficacy of doxorubicin delivered in multifunctional microparticles for mesothelioma therapy. | Int J Cancer | 2011 | https://conductscience.org/library/papers/20830711 | PubMed |
| 18 | 18593991 | Multiple mechanisms of telomere maintenance exist and differentially affect clinical outcome in diffuse malignant peritoneal mesothelioma. | Clin Cancer Res | 2008 | https://conductscience.org/library/papers/18593991 | PubMed |
| 19 | 21376534 | Microparticles as antigenic targets of antibodies to DNA and nucleosomes in systemic lupus erythematosus. | J Autoimmun | 2011 | https://conductscience.org/library/papers/21376534 | PubMed |
| 20 | 20801099 | Microparticles mediate enzyme transfer from platelets to mast cells: a new pathway for lipoxin A4 biosynthesis. | Biochem Biophys Res Commun | 2010 | https://conductscience.org/library/papers/20801099 | PubMed |
Cited by200
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 370 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42919905 | Autologous erythrocyte microparticles drive antitumour T cell immunity via haem-mediated dendritic cell activation. | Nat Biomed Eng | 2026 | https://conductscience.org/library/papers/42919905 | PubMed |
| 42606797 | Regenerative strategies for ALS: stem cells and extracellular vesicles. | Discov Nano | 2026 | https://conductscience.org/library/papers/42606797 | PubMed |
| 41944389 | Chemoradiotherapy-Integrated Tumor Cell-Derived Microparticles Mediate Tumor Eradication in Malignant Pleural Effusion. | J Extracell Vesicles | 2026 | https://conductscience.org/library/papers/41944389 | PubMed |
| 41629133 | Oncolytic virus OH2 induces PD-L1 upregulation via NF-κB signaling and synergizes with anti-PD-L1 therapy in prostate cancer through a targeted extracellular vesicle delivery system. | J Immunother Cancer | 2026 | https://conductscience.org/library/papers/41629133 | PubMed |
| 41261428 | Mesenchymal stem cell-derived exosomes as cell-free therapeutics: mechanistic insights and engineering strategies for liver disease treatment. | Stem Cell Res Ther | 2025 | https://conductscience.org/library/papers/41261428 | PubMed |
| 41179975 | Extracellular Vesicle-Based Therapeutic Cargo Delivery for Cancer Therapy. | Int J Nanomedicine | 2025 | https://conductscience.org/library/papers/41179975 | PubMed |
| 41016975 | Immune-based cancer therapies: mechanistic insights, clinical progress, and future directions. | J Egypt Natl Canc Inst | 2025 | https://conductscience.org/library/papers/41016975 | PubMed |
| 40871036 | Extracellular Vesicle-Mediated Delivery of AntimiR-Conjugated Bio-Gold Nanoparticles for In Vivo Tumor Targeting. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/40871036 | PubMed |
| 40650799 | Stem Cell for Cancer Immunotherapy: Current Approaches and Challenges. | Stem Cell Rev Rep | 2025 | https://conductscience.org/library/papers/40650799 | PubMed |
| 40636726 | The potential role of extracellular vesicles as hepatic diagnostic and therapeutic tools: Can the dream come true? | ILIVER | 2024 | https://conductscience.org/library/papers/40636726 | PubMed |
| 40321799 | The Radiosensitizing Effect of Tumor-Derived Microparticles Co-Loaded with Sorafenib and Gold Nanoparticles on Hepatocellular Carcinoma. | Int J Nanomedicine | 2025 | https://conductscience.org/library/papers/40321799 | PubMed |
| 40078996 | Prospect of extracellular vesicles in tumor immunotherapy. | Front Immunol | 2025 | https://conductscience.org/library/papers/40078996 | PubMed |
| 39961904 | Exosomes and solid cancer therapy: where are we now? | Med Oncol | 2025 | https://conductscience.org/library/papers/39961904 | PubMed |
| 39875472 | A study on the production of extracellular vesicles derived from novel immortalized human placental mesenchymal stromal cells. | Sci Rep | 2025 | https://conductscience.org/library/papers/39875472 | PubMed |
| 39547584 | Roles of extracellular vesicles from mesenchymal stem cells in regeneration. | Mol Cells | 2024 | https://conductscience.org/library/papers/39547584 | PubMed |
| 39493304 | Extracellular vesicle mimetics as delivery vehicles for oligonucleotide-based therapeutics and plasmid DNA. | Front Bioeng Biotechnol | 2024 | https://conductscience.org/library/papers/39493304 | PubMed |
| 39339242 | Characterizing Extracellular Vesicles Generated from the Integra CELLine Culture System and Their Endocytic Pathways for Intracellular Drug Delivery. | Pharmaceutics | 2024 | https://conductscience.org/library/papers/39339242 | PubMed |
| 39229670 | Exosomes That Have Different Cellular Origins Followed by the Impact They Have on Prostate Tumor Development in the Tumor Microenvironment. | Cancer Rep (Hoboken) | 2024 | https://conductscience.org/library/papers/39229670 | PubMed |
| 39204374 | Extracellular Vesicles as Drug Delivery System for Cancer Therapy. | Pharmaceutics | 2024 | https://conductscience.org/library/papers/39204374 | PubMed |
| 39113040 | Harnessing exosomes as cancer biomarkers in clinical oncology. | Cancer Cell Int | 2024 | https://conductscience.org/library/papers/39113040 | PubMed |
Drugs1
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets |
|---|---|---|---|---|
| METHOTREXATE | CHEMBL34259 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL34259 |
Source ChEMBL
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Genes
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23250412
GET https://conductscience.org/api/papers/v1/23250412/references?page=2